Chris Viehbacher, sacked as chief executive of French drugs firm Sanofi last year, is to join the board of PureTech, a privately owned healthcare science and technology R&D company. Boston-based PureTech's co-founder and senior partner Robert Langer said in a statement he had known the German-Canadian Viehbacher for many years "and I am very excited that we will be working together more closely now". Viehbacher, who moved to Boston last year while he was still running Sanofi, raised the French company's multinational profile during his six years in the job by completing over $30 billion of acquisitions including that of Boston-based Genzyme. PureTech is a portfolio company that aims to commercialize breakthrough technologies and solve healthcare problems.
via Tech News Headlines - Yahoo News http://ift.tt/1zlK5uf
Brak komentarzy:
Prześlij komentarz